Shares of Apple Inc. (NASDAQ:AAPL) [Trend Analysis] runs in leading trade, it surging 0.18% to traded at $120.00. The firm has price volatility of 0.85% for a week and 0.98% for a month. Its beta stands at 1.24 times. Apple Inc. (AAPL) declared that it is willing to start making iPhones in India, but it wants a big helping hand from the Indian government first, according to reports. The Cupertino, California-based company is slated to meet with officials in New Delhi next week to discuss the prospects for setting up manufacturing facilities in the country this year.
Apple is asking for a long list of financial concessions from India. Among the requests, the company is seeking a 15-year tax holiday on imports of components and equipment, the reports said.Chief Executive Officer Tim Cook visited the country for the first time in May as he sought government approval for Apple to open its own stores. India has insisted that Apple, like any single-brand retailer, source 30 percent of its components locally, though the country is relaxing those rules so technology companies can operate stores for three years before meeting that requirement. Narrow down four to firm performance, its weekly performance was 0.63% and monthly performance was 2.88%. The stock price of AAPL is moving up from its 20 days moving average with 1.87% and isolated positively from 50 days moving average with 5.35%.
Interpace Diagnostics Group, Inc. (NASDAQ:IDXG) [Trend Analysis] luring active investment momentum, shares a loss -5.87% to $4.33. Interpace Diagnostics Group, Inc. (IDXG) reported that it has entered into a securities purchase contract with three institutional investors to purchase an aggregate of 855,000 shares of common stock in a registered direct offering. In a concurrent private placement, the Company has agreed to sell to the same investors warrants to purchase 855,000 shares of its common stock with an exercise price of $4.69 per share.
The combined purchase price for one registered share of common stock and one warrant is $4.69. The warrants will be immediately exercisable following the closing of the private placement and will expire on the five-year anniversary of the date on which they become exercisable.
The aggregate gross proceeds to the Company from the registered direct offering and concurrent private placement are estimated to be approximately $4.0 million before deducting the placement agent’s fee and other estimated offering expenses. The registered direct offering and concurrent private placement are expected to close on or about January 25, 2017, subject to customary closing conditions. The total volume of 6.35 Million shares held in the session was surprisingly higher than its average volume of 5041.72 shares. EPS estimates indicating constrictive facts, the current year from sell-side analysts, Price to current year EPS stands at -122.20%. While take a short look on price to sales ratio, that was 1.03.